vs
DBV Technologies S.A.(DBVT)与Instil Bio, Inc.(TIL)财务数据对比。点击上方公司名可切换其他公司
DBV Technologies S.A.的季度营收约是Instil Bio, Inc.的1.2倍($2.8M vs $2.2M),Instil Bio, Inc.净利率更高(-365.3% vs -1195.5%,领先830.2%),DBV Technologies S.A.同比增速更快(158.8% vs -19.2%)
DBV Technologies是一家总部位于法国巴涅的公开上市生物制药企业,核心研发成果为Viaskin给药技术,可在不进入血液循环的前提下,让过敏原或抗原作用于完整皮肤。其花生过敏疗法Viaskin Peanut的临床开发,已获得美国食品药品监督管理局授予快速通道资格。
Instil Bio Inc.是一家临床阶段生物技术企业,专注于研发肿瘤浸润淋巴细胞(TIL)疗法,用于治疗难治性晚期实体瘤,面向对现有标准癌症治疗方案应答有限的患者群体,核心业务属于肿瘤免疫疗法领域。
DBVT vs TIL — 直观对比
营收规模更大
DBVT
是对方的1.2倍
$2.2M
营收增速更快
DBVT
高出177.9%
-19.2%
净利率更高
TIL
高出830.2%
-1195.5%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $2.8M | $2.2M |
| 净利润 | $-33.2M | $-8.2M |
| 毛利率 | — | — |
| 营业利润率 | -1235.7% | -426.3% |
| 净利率 | -1195.5% | -365.3% |
| 营收同比 | 158.8% | -19.2% |
| 净利润同比 | -8.9% | 31.1% |
| 每股收益(稀释后) | $-0.24 | $-1.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DBVT
TIL
| Q4 25 | — | $2.2M | ||
| Q3 25 | $2.8M | $2.2M | ||
| Q2 25 | $1.5M | $2.2M | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | — | $2.8M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | $1.2M | $0 | ||
| Q1 24 | $1.4M | $0 |
净利润
DBVT
TIL
| Q4 25 | — | $-8.2M | ||
| Q3 25 | $-33.2M | $-13.6M | ||
| Q2 25 | $-41.9M | $-21.4M | ||
| Q1 25 | — | $-28.2M | ||
| Q4 24 | — | $-11.9M | ||
| Q3 24 | — | $-23.0M | ||
| Q2 24 | $-33.1M | $-14.9M | ||
| Q1 24 | $-27.3M | $-24.3M |
营业利润率
DBVT
TIL
| Q4 25 | — | -426.3% | ||
| Q3 25 | -1235.7% | -670.0% | ||
| Q2 25 | -2806.2% | -1045.5% | ||
| Q1 25 | — | -1363.2% | ||
| Q4 24 | — | -426.1% | ||
| Q3 24 | — | -1582.8% | ||
| Q2 24 | -2914.9% | — | ||
| Q1 24 | -2029.7% | — |
净利率
DBVT
TIL
| Q4 25 | — | -365.3% | ||
| Q3 25 | -1195.5% | -606.0% | ||
| Q2 25 | -2858.4% | -954.2% | ||
| Q1 25 | — | -1257.8% | ||
| Q4 24 | — | -428.8% | ||
| Q3 24 | — | -1541.9% | ||
| Q2 24 | -2852.4% | — | ||
| Q1 24 | -1943.5% | — |
每股收益(稀释后)
DBVT
TIL
| Q4 25 | — | $-1.13 | ||
| Q3 25 | $-0.24 | $-2.01 | ||
| Q2 25 | $-0.31 | $-3.24 | ||
| Q1 25 | — | $-4.32 | ||
| Q4 24 | — | $-1.82 | ||
| Q3 24 | — | $-3.54 | ||
| Q2 24 | $-0.34 | $-2.29 | ||
| Q1 24 | $-0.28 | $-3.74 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $69.8M | $6.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $52.9M | $113.9M |
| 总资产 | $110.5M | $203.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
DBVT
TIL
| Q4 25 | — | $6.6M | ||
| Q3 25 | $69.8M | $5.8M | ||
| Q2 25 | $103.2M | $7.7M | ||
| Q1 25 | — | $15.4M | ||
| Q4 24 | — | $8.8M | ||
| Q3 24 | — | $6.7M | ||
| Q2 24 | $66.2M | $6.8M | ||
| Q1 24 | $101.5M | $5.5M |
股东权益
DBVT
TIL
| Q4 25 | — | $113.9M | ||
| Q3 25 | $52.9M | $120.4M | ||
| Q2 25 | $86.2M | $131.7M | ||
| Q1 25 | — | $144.9M | ||
| Q4 24 | — | $169.4M | ||
| Q3 24 | — | $176.3M | ||
| Q2 24 | $79.1M | $195.0M | ||
| Q1 24 | $111.7M | $205.8M |
总资产
DBVT
TIL
| Q4 25 | — | $203.5M | ||
| Q3 25 | $110.5M | $211.8M | ||
| Q2 25 | $143.4M | $231.0M | ||
| Q1 25 | — | $237.4M | ||
| Q4 24 | — | $263.6M | ||
| Q3 24 | — | $272.6M | ||
| Q2 24 | $114.2M | $294.3M | ||
| Q1 24 | $145.9M | $306.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-32.4M | $-7.1M |
| 自由现金流经营现金流 - 资本支出 | $-32.6M | — |
| 自由现金流率自由现金流/营收 | -1173.5% | — |
| 资本支出强度资本支出/营收 | 4.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-138.3M | — |
8季度趋势,按日历期对齐
经营现金流
DBVT
TIL
| Q4 25 | — | $-7.1M | ||
| Q3 25 | $-32.4M | $-10.6M | ||
| Q2 25 | $-33.9M | $-14.8M | ||
| Q1 25 | — | $-4.2M | ||
| Q4 24 | — | $-10.6M | ||
| Q3 24 | — | $-20.1M | ||
| Q2 24 | $-35.1M | $-10.6M | ||
| Q1 24 | $-34.7M | $-14.4M |
自由现金流
DBVT
TIL
| Q4 25 | — | — | ||
| Q3 25 | $-32.6M | — | ||
| Q2 25 | $-33.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-35.8M | — | ||
| Q1 24 | $-36.0M | — |
自由现金流率
DBVT
TIL
| Q4 25 | — | — | ||
| Q3 25 | -1173.5% | — | ||
| Q2 25 | -2316.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3084.0% | — | ||
| Q1 24 | -2560.6% | — |
资本支出强度
DBVT
TIL
| Q4 25 | — | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 63.0% | — | ||
| Q1 24 | 94.9% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图